You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 106 No. 4, October 1972 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (69)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Lupus Erythematosus

Denny L. Tuffanelli, MD

Arch Dermatol. 1972;106(4):553-566.


Abstract



A genetically predetermined host immune response apparently disposes certain individuals to develop lupus erythematosus. Drugs, ultraviolet light, and viral infection are among the sources of antigenic stimulation. Patients with milder forms of the disease, such as discoid lupus, may have a protective immune response.

Knowledge of the clinical manifestations of lupus erythematosus provides the basic tool for patient management. However, rapid advances in technology have been of real value in diagnosis and estimation of disease activity. Serological studies of antibodies to DNA and RNA, estimation of serum and spinal fluid complement components, direct and indirect immunofluorescence, and electron microscopy are all of use to the clinician.

Corticosteroids remain the main therapeutic agent in serious forms of the disease. Antimalarials are of proven value. The role of the immunosuppressive agents is still problematical.



Author Affiliations



San Francisco

From the Department of Dermatology, University of California School of Medicine, San Francisco.


Footnotes



Accepted for publication May 4, 1972.

Reprint requests to Department of Dermatology, University of California School of Medicine, San Francisco 94122, (Dr. Tuffanelli).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Questions Answered and a $1 Million Question Raised Concerning Lupus Erythematosus Tumidus: Is Routine Laboratory Surveillance Testing During Treatment With Hydroxychloroquine for Skin Disease Really Necessary?
Sontheimer
Arch Dermatol 2000;136:1044-1049.
FULL TEXT  

Bullous Pemphigoid in a Man and His Nephew
Miyagawa et al.
Arch Dermatol 1983;119:605-606.
ABSTRACT  

Placental Transfer of Anticytoplasmic Antibodies in Annular Erythema of Newborns
Miyagawa et al.
Arch Dermatol 1981;117:569-572.
ABSTRACT  

Abnormal Laboratory Test Results and Their Relationship to Prognosis in Discoid Lupus Erythematosus: A Long-term Follow-up Study of 92 Patients
Millard and Rowell
Arch Dermatol 1979;115:1055-1058.
ABSTRACT  

Cutaneous Lupus Erythematosus Associated With Melanoma and BCG Vaccine Therapy
Herstoff and Bogaars
Arch Dermatol 1979;115:856-859.
ABSTRACT  

Systemic Lupus Erythematosus: Association With Psoralen-Ultraviolet-A Treatment of Psoriasis
Eyanson et al.
Arch Dermatol 1979;115:54-56.
ABSTRACT  

Concurrent Localized Scleroderma and Discoid Lupus Erythematosus: Cutaneous `Mixed' or `Overlap' Syndrome
Umbert and Winkelmann
Arch Dermatol 1978;114:1473-1478.
ABSTRACT  

Lichen Planus and Discoid Lupus Erythematosus: Overlap Syndrome Associated With Cryoglobulinemia and Hypocomplementemia
Jamison et al.
Arch Dermatol 1978;114:1039-1042.
ABSTRACT  

p-Aminobenzoic-Acid-Related Compounds and Systemic Lupus
Pereyo-Torrellas
Arch Dermatol 1978;114:1097-1097.
ABSTRACT  

Speckled (Particulate) Epidermal Nuclear IgG Deposition in Normal Skin: Correlation of Clinical Features and Laboratory Findings in 46 Patients With a Subset of Connective Tissue Disease Characterized by Antibody to Extractable Nuclear Antigen
Prystowsky and Tuffanelli
Arch Dermatol 1978;114:705-710.
ABSTRACT  

Epidermal Nucleolar IgG Deposition in Clinically Normal Skin: Clinical and Serologic Features of Eight Patients
Prystowsky et al.
Arch Dermatol 1978;114:536-538.
ABSTRACT  

Unusual Variant of Lupus Erythematosus or Lichen Planus: Clinical, Histopathologic, and Immunofluorescent Studies
Romero et al.
Arch Dermatol 1977;113:741-748.
ABSTRACT  

Collagen Disease in Children: A Review of 71 Cases
Coleman et al.
JAMA 1977;237:1095-1100.
ABSTRACT  

Society Transactions
Arch Dermatol 1976;112:1041-1042.
ABSTRACT  

IgA Deficiency and Systemic Lupus Erythematosus: Occurrence in an Oriental Woman With Idiopathic Epilepsy
Takigawa et al.
Arch Dermatol 1976;112:845-849.
ABSTRACT  

Neonatal Lupus Erythematosus: Report of Four Cases With Review of the Literature
Vonderheid et al.
Arch Dermatol 1976;112:698-705.
ABSTRACT  

Systemic Lupus Erythematosus: Contrasts and Comparisons
DECKER et al.
ANN INTERN MED 1975;82:391-404.
ABSTRACT  

Criteria for Classification of Systemic Lupus Erythematosus
Rabhan and Minkin
JAMA 1975;231:846-846.
ABSTRACT  

Criteria for Systemic Lupus Erythematosus
Rabhan and Minkin
Arch Dermatol 1974;110:807-807.
ABSTRACT  

Dermatitis Herpetiformis With Discoid Lupus Erythematosus: Occurrence of Sulfone-Induced Discoid Lupus Erythematosus
Vandersteen and Jordon
Arch Dermatol 1974;110:95-98.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.